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Deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH) are essential for hypusination of
eukaryotic translation initiation factor 5A (eIF-5A). In this issue, Han et al. use X-ray crystallograpy and UV/Vis
and Mo¨ssbauer spectroscopy to provide insights into the fundamental mechanism of the hypusination of
eIF-5A and a peroxo intermediate state.The non-heme diiron enzymes catalyzing
the oxidation of hydrocarbons became
the focus of industrial applications, like
the soluble methane monooxygenase hy-
droxylase (sMMOH) frommethanotrophic
bacteria, which oxidizes methane to
methanol (Tinberg and Lippard, 2011).
The first step of its reaction cycle
(Figure 1) is the interaction of the reduced
(Fe(II)-Fe(II)) form of the enzyme with
dioxygen to yield a peroxo-diiron(III) spe-
cies named P. This intermediate is subse-
quently converted into a species termed
Q, which contains an Fe(IV)-Fe(IV) core
(Wallar and Lipscomb, 1996), and is
believed to perform the oxidation of
methane.
The intermediates P and Q are only
short-lived. A few weeks ago, time-
resolved Resonance Raman spectros-
copy confirmed the Fe2(m-O)2 diamond
structure of Q (Banerjee et al., 2015).
The data showed that both m-oxygen
atoms of Q are derived from O2, and sug-Figure 1. Catalytic Cycle of sMMOHgested homolytic O-O bond cleav-
age via intermediates such as (I) on
the P/Q path (Figure 1), but not
the heterolytic mechanisms (II and
III) that require the protonation of
the peroxo ligand (Solomon et al.,
2000; Xue et al., 2008).
For the structure of the peroxo-
diiron(III) intermediate P, which pre-
cedes Q, various configurations
have been reviewed. These include
m-1,2 (h1,h1-1,2; either cis [I in
Figure 2A] or trans [II in Figure 2A]),
an h2,h2-1,2 (III in Figure 2A), and a
m-1,1 (h1,h1-1,1; IV in Figure 2A)
arrangement of the peroxo ligand
(Tinberg and Lippard, 2011). Like
Q, the P intermediate of sMMOH is
very short-lived (t1/2 of about 1.5 sat 4C) (Liu et al., 1995), making spectro-
scopic work difficult.
Importantly, there is a human non-
heme diiron oxygenase called deoxyhy-
pusine hydroxylase (hDOHH) in which
the peroxo-diiron(III) intermediate is sta-
ble. Previous Resonance Raman studies
of this intermediate suggested a m-1,2
interaction of the peroxide ion with the
diiron core (Vu et al., 2009). In this issue
of Structure, Han et al. (2015) now present
two crystal structures of hDOHH, one of
the peroxo-diiron(III) intermediates, and
the other of a complex with glycerol.
Through time-dependent UV/Vis spectra
of the intermediate, which is colored
blue (absorption maximum at 630 nm),
they show that the peroxo species, which
they have crystallized, does not corre-
spond to the one formed immediately af-
ter the reaction of the reduced form of
hDOHH with O2, but to a slightly different
one obtained over the time of crystalliza-
tion (48 hr). This is supported by Mo¨ssba-Structure 23, May 5, 2015uer spectra of the 57Fe-hDOHH in the
crystals, which differ slightly from those
obtained from freshly prepared hDOHH
in solution. In any case, Han et al.
describe here the crystal structure of a
native peroxo intermediate of a non-
heme diiron enzyme. The 1.7 A˚ struc-
ture reveals a cis-m-1,2 arrangement
(cis-h1,h1-1,2; scheme I of Figure 2A) of
the peroxo unit, with a gauche Fe-O-O-
Fe torsion angle. Remarkably, the O1-
atom of the peroxide is more centrally
placed between the two iron atoms (2.2
and 2.6 A˚ from Fe1 and Fe2, respectively),
whereas O2 is basically interacting only
with Fe2 (3.5 and 2.2 A˚ from Fe1 and
Fe2, respectively) (Figure 2B). While this
asymmetric arrangement is still cis-m-1,2
(h1,h1-1,2), it is not far from an h1,h2-1,2
arrangement (V of Figure 2A), a configura-
tion that has very recently been proposed
on the basis of spectroscopic data for the
peroxo intermediate of a bacterial aryl
oxygenase (Makris et al., 2015). The lackª201of true isosbestic points in the
time-dependent UV/Vis spectra re-
ported by Han et al. (2015) suggests
that the peroxo intermediate may
adopt a continuum of configurations
and this may be reflected in the
slight differences observed between
the twomolecules in the asymmetric
unit of the hDOHH crystal.
The crystallographic work of Han
et al. also reveals the reason for the
unusual stability of the peroxo inter-
mediate of hDOHH: in contrast to all
other well-characterized non-heme
diiron enzymes, hDOHH features a
histidine-rich coordination of the
diiron core lacking any bridging car-
boxylates. The histidines coordinate
iron through their Nε-atoms, not5 Elsevier Ltd All rights reserved 805
Figure 2. Peroxo-diiron(III) Core
(A) Possible geometries for the peroxo-diiron(III) core of diiron-containing oxygenases; (B) Fo-Fc difference
density (contoured at 4.7s) for the non-protein ligands of the diiron core of hDOHH. The corresponding
difference map was calculated after building the protein ligands but before incorporating the peroxo,
and water ligands.
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oxygenases. Furthermore, the secondary
ligation hemisphere surrounding the bind-
ing site for the peroxide ion is very hydro-
phobic, shielding the reactive intermedi-
ate by a methionine pair and a leucine
pair. Importantly, potential hydrogen-
bonding donors such as threonine, which
occur in many O2-activating monooxyge-
nases, where they seem to shuttle pro-
tons to the active site (Wallar and Lips-
comb, 1996), are completely absent
from the hDOHH active site; therefore,
the heterolytic breakdown of the peroxide
resulting from protonation is greatly
delayed.
A high-oxidation state intermediate
such as compound Q has so far not
been described for hDOHH, and perhaps
there is no requirement for it. In the
sMMOH system, Q is the active species
that breaks the unusually strong (DH =
105 kcal mol1) C-H bond in methane to
insert oxygen. However, the peroxo-diiro-
n(III) intermediate P of sMMOH is by itself
able to oxidize electron-rich hydrocar-
bons such as diethyl ether or propylene806 Structure 23, May 5, 2015 ª2015 Elsevie(indicated by the direct pathway between
P and Hox in Figure 1) (Tinberg and Lip-
pard, 2010).
There is only one substrate known for
DOHH: deoxyhypusine eukaryotic trans-
lation initiation factor 5A (eIF-5A). The
various functions of this protein in transla-
tion initiation and elongation (in particular
of oligoproline-containing polypeptide
segments) and in nuclear export of retro-
viral RNA, CD83 mRNA, and iNOS
mRNA depend on the elongation of an
exposed lysine residue (K50 in the human
protein) by attachment of a 2-hydroxo-4-
amino butyl unit. This unique posttransla-
tional modification is performed in a
two-step reaction catalyzed by the en-
zymes deoxyhypusine synthase (DHS)
and DOHH (Park, 2006). In the first step,
DHS attaches a 4-aminobutyl group orig-
inating from spermidine to the Nz atom of
residue K50, to yield deoxyhypusine-eIF-
5A (Dhp-eIF-5A). In the second step,
DOHH hydroxylates Dhp-eIF-5A in the
2-position of the 4-aminobutyl group,
thereby affording hypusine-eIF-5A (Hpu-
eIF-5A). The structures presented byr Ltd All rights reservedHan et al. (2015) immediately suggest
how the substrate and the product would
bind to human DOHH. This in itself is a
major achievement, as hDOHH could
well act as a target for the development
of therapeutics for the treatment of HIV/
AIDS, certain cancers, and diabetes (Kai-
ser, 2012).REFERENCES
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